7Baggers

MicroVision, Inc
(NASDAQ:MVIS) 

MVIS stock logo

MicroVision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms and software. The company also develops micro-display conc...

Founded: 1993
Full Time Employees: 30
Sector: Technology
Industry: Scientific & Technical Instruments

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2004-09-30 2001-03-31 2000-12-31 
                                                                    
      revenue
    935,000 223,000 241,000 155,000 589,000 1,650,000 190,000 1,900,000 956,000 5,101,000 1,047,000 329,000 782,000                                                  2,337,000  
      yoy
    58.74% -86.48% 26.84% -91.84% -38.39% -67.65% -81.85% 477.51% 22.25%                                                        
      qoq
    319.28% -7.47% 55.48% -73.68% -64.30% 768.42% -90.00% 98.74% -81.26% 387.20% 218.24% -57.93%                                                     
      cost of revenue
    572,000 16,325,000 957,000 716,000 550,000 4,116,000 583,000 1,554,000 1,277,000 902,000 625,000 701,000 544,000                                                  1,562,000  
      gross profit
    363,000   -561,000 39,000 -2,466,000 -393,000 346,000  4,199,000 422,000 -372,000 238,000 -33,000 -45,000 296,000 346,000 509,000 728,000 777,000 484,000 395,000 639,000 588,000 70,000 1,179,000 -882,000 -583,000 608,000 -2,606,000 8,927,000 333,000 315,000 10,000 243,000 508,000 254,000 505,000 1,207,000 1,563,000 1,112,000 379,000 585,000 1,187,000 -143,000                    
      yoy
    830.77%   -262.14%  -158.73% -193.13% -193.01%  -12824.24% -1037.78% -225.68% -31.21% -106.48% -106.18% -61.90% -28.51% 28.86% 13.93% 32.14% 591.43% -66.50% -172.45% -200.86% -88.49% -145.24% -109.88% -275.08% 93.02% -26160.00% 3573.66% -34.45% 24.02% -98.02% -79.87% -67.50% -77.16% 33.25% 106.32% 31.68% -877.62%                        
      qoq
       -1538.46% -101.58% 527.48% -213.58%   895.02% -213.44% -256.30% -821.21% -26.67% -115.20% -14.45% -32.02% -30.08% -6.31% 60.54% 22.53% -38.18% 8.67% 740.00% -94.06% -233.67% 51.29% -195.89% -123.33% -129.19% 2580.78% 5.71% 3050.00% -95.88% -52.17% 100.00% -49.70% -58.16% -22.78% 40.56% 193.40% -35.21% -50.72% -930.07%                     
      gross margin %
    38.82% 0% 0% -361.94% 6.62% -149.45% -206.84% 18.21% 0% 82.32% 40.31% -113.07% 30.43% -Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% -Infinity% -Infinity% Infinity% -Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 0%  
      research and development expense
    14,445,000 8,681,000 7,978,000 7,658,000 7,403,000 8,764,000 8,736,000 14,204,000 17,311,000 14,580,000 15,584,000 13,851,000 12,692,000 7,585,000 7,535,000 7,700,000 7,593,000 6,482,000 5,791,000 7,376,000 4,462,000 2,578,000 1,972,000 1,607,000 3,683,000 3,177,000 3,566,000 5,945,000 5,973,000 6,761,000 6,386,000 6,691,000 4,828,000 4,679,000 3,427,000 3,672,000 3,318,000 3,605,000 3,053,000 2,879,000 2,597,000 2,540,000 2,231,000 2,011,000 1,898,000 1,919,000 2,369,000 2,236,000 2,543,000 2,783,000 2,893,000 2,339,000 2,252,000 2,871,000 3,097,000 3,227,000 3,940,000 3,833,000 3,641,000 3,478,000 4,327,000 4,666,000 8,067,000  
      sales, marketing, general and administrative expense
    9,511,000 3,185,000 4,027,000 6,437,000 6,676,000 5,923,000 6,599,000 7,746,000 9,078,000 9,517,000 8,743,000 9,692,000 8,737,000 6,377,000 5,522,000 6,265,000 5,877,000 6,648,000 5,006,000 8,355,000 2,247,000 1,381,000 1,485,000 1,280,000 1,771,000 1,282,000 1,697,000 2,455,000 2,699,000 2,570,000 2,253,000 2,093,000 2,607,000 3,189,000 2,062,000 2,325,000 2,580,000 2,273,000 2,231,000 2,171,000 2,068,000 2,139,000 1,873,000 1,946,000 1,921,000 1,589,000 1,588,000 1,869,000 1,959,000 2,156,000 2,132,000 2,101,000 2,403,000 2,475,000 2,425,000 3,064,000 3,288,000 3,132,000 3,306,000 3,577,000 3,299,000    
      impairment loss on operating lease right-of-use assets
    9,000                                                                
      gain on disposal of fixed assets
    -108,000     -5,500 -22,000   -9,000 -10,000 -15,000             -450,000                     -7,250  -28,000   -33,000   -32,000 -46,000          
      total operating expenses
    23,857,000 25,309,000 12,005,000 14,095,000 14,079,000 16,006,000 15,313,000 24,977,000 26,389,000 24,088,000 24,317,000 23,528,000 21,429,000 13,962,000 13,057,000 13,965,000 13,470,000 13,130,000 10,797,000 15,731,000 6,709,000 3,959,000 3,457,000 2,887,000 5,004,000 4,459,000 5,263,000 8,400,000 8,672,000 9,331,000 8,639,000 8,784,000 7,435,000 7,868,000 5,489,000 5,997,000 5,898,000 5,846,000 5,284,000 5,050,000 4,665,000 4,679,000 4,103,000 3,957,000 3,819,000 3,529,000 3,956,000 3,849,000 4,275,000 5,060,000 4,992,000 4,440,000 4,653,000 5,314,000 5,476,000 6,290,000 7,228,000 6,965,000 6,943,000 7,055,000 7,619,000 9,600,000 12,231,000  
      income from operations
    -23,494,000 -41,411,000 -12,721,000 -14,656,000 -14,040,000 -18,472,000 -15,706,000 -24,631,000 -26,710,000 -19,889,000 -23,895,000 -23,900,000 -21,191,000 -13,995,000 -13,102,000 -13,669,000 -13,124,000 -12,621,000 -10,069,000 -14,954,000 -6,225,000 -3,564,000 -2,818,000 -2,299,000 -4,934,000 -3,280,000 -6,145,000 -8,983,000 -8,064,000 -11,937,000 288,000 -8,451,000 -7,120,000 -7,858,000 -5,246,000 -5,489,000 -5,644,000 -5,341,000 -4,077,000 -3,487,000 -3,553,000 -4,300,000 -3,518,000 -2,770,000 -3,962,000 -3,351,000 -3,356,000 -3,406,000 -3,055,000 -3,896,000 -4,112,000 -3,433,000 -3,653,000 -4,076,000 -4,001,000 -4,962,000 -9,828,000 -9,887,000 -7,824,000 -9,280,000 -9,039,000  -11,456,000  
      yoy
    67.34% 124.18% -19.01% -40.50% -47.44% -7.12% -34.27% 3.06% 26.04% 42.12% 82.38% 74.85% 61.47% 10.89% 30.12% -8.59% 110.83% 254.12% 257.31% 550.46% 26.17% 8.66% -54.14% -74.41% -38.81% -72.52% -2233.68% 6.30% 13.26% 51.91% -105.49% 53.96% 26.15% 47.13% 28.67% 57.41% 58.85% 24.21% 15.89% 25.88% -10.32% 28.32% 4.83% -18.67% 29.69% -13.99% -18.39% -0.79% -16.37% -4.42% 2.77% -30.81% -62.83% -58.77% -48.86% -46.53% 8.73%  -31.70%      
      qoq
    -43.27% 225.53% -13.20% 4.39% -23.99% 17.61% -36.23% -7.78% 34.30% -16.77% -0.02% 12.78% 51.42% 6.82% -4.15% 4.15% 3.99% 25.35% -32.67% 140.22% 74.66% 26.47% 22.58% -53.40% 50.43% -46.62% -31.59% 11.40% -32.45% -4244.79% -103.41% 18.69% -9.39% 49.79% -4.43% -2.75% 5.67% 31.00% 16.92% -1.86% -17.37% 22.23% 27.00% -30.09% 18.23% -0.15% -1.47% 11.49% -21.59% -5.25% 19.78% -6.02% -10.38% 1.87% -19.37% -49.51% -0.60% 26.37% -15.69% 2.67%     
      operating margin %
    -2512.73% -18569.96% -5278.42% -9455.48% -2383.70% -1119.52% -8266.32% -1296.37% -2793.93% -389.90% -2282.23% -7264.44% -2709.85% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% -490.20%  
      interest expense
    -2,753,000 -1,261,000 -2,197,000 -2,170,000 -12,903,000                                                     -12,000  -12,000 -13,000  -24,000  
      unrealized gain on derivative liability
    3,380,000 1,856,000 1,059,000 1,952,000 842,000                                                            
      unrealized gain on warrant liability
    604,000 2,184,000 -326,000 803,000 1,761,000                                                            
      realized loss on debt extinguishment
    -3,083,000    -4,654,000                                                            
      bargain purchase gain
    147,000                                                                
      other income
    87,000 454,000 140,000 -65,000 288,000 721,000 297,000 785,000 631,000 664,000 637,000 3,570,000 639,000 520,000 251,000 72,000           4,000   -4,750 1,000    5,000   -29,000 7,000 11,000  2,000 5,000 1,000  5,000 1,000 5,000 4,000 71,000 48,000   2,000 156,000  24,000 82,000 34,000 105,000     
      net loss before taxes
    -25,112,000 -38,178,000 -14,045,000 -14,136,000 -28,706,000 -31,074,000 -15,409,000 -23,846,000 -26,079,000 -19,262,000 -23,258,000 -20,330,000 -18,846,000                                                    
      income tax expense
    -182,000 -84,500 -172,000 -93,000 -73,000 -81,000 -108,000 -84,000 -234,000 -475,000 -211,000 -279,000                                                     
      net income
    -25,294,000 -37,756,000 -14,217,000 -14,229,000 -28,779,000 -31,155,000 -15,517,000 -23,930,000 -26,313,000 -19,737,000 -23,469,000 -20,609,000 -19,027,000 -13,475,000 -12,851,000 -13,597,000 -13,168,000 -12,625,000 -9,382,000 -14,962,000 -6,231,000 -3,570,000 -2,826,000 -2,304,000 -4,934,000 -3,284,000 -6,141,000 -8,990,000 -8,068,000 -11,948,000 289,000 -8,459,000 -7,132,000 -7,861,000 -5,241,000 -5,494,000 -5,647,000 -5,370,000 -4,070,000 -3,476,000 -3,556,000 -4,298,000 -3,513,000 -2,769,000 -3,962,000 -3,346,000 -3,355,000 -3,401,000 -8,018,000 -2,421,000 -3,667,000 -3,436,000 -3,654,000 -4,074,000 -3,845,000 -4,971,000 -9,803,000 -9,806,000 -7,790,000 -9,175,000 -9,037,000  -10,220,000  
      yoy
    -12.11% 21.19% -8.38% -40.54% 9.37% 57.85% -33.88% 16.11% 38.29% 46.47% 82.62% 51.57% 44.49% 6.73% 36.98% -9.12% 111.33% 253.64% 231.99% 549.39% 26.29% 8.71% -53.98% -74.37% -38.84% -72.51% -2224.91% 6.28% 13.12% 51.99% -105.51% 53.97% 26.30% 46.39% 28.77% 58.06% 58.80% 24.94% 15.86% 25.53% -10.25% 28.45% 4.71% -18.58% -50.59% 38.21% -8.51% -1.02% 119.43% -40.57% -4.63% -30.88% -62.73% -58.45% -50.64% -45.82% 8.48%  -23.78%      
      qoq
    -33.01% 165.57% -0.08% -50.56% -7.63% 100.78% -35.16% -9.06% 33.32% -15.90% 13.88% 8.31% 41.20% 4.86% -5.49% 3.26% 4.30% 34.57% -37.29% 140.12% 74.54% 26.33% 22.66% -53.30% 50.24% -46.52% -31.69% 11.43% -32.47% -4234.26% -103.42% 18.61% -9.27% 49.99% -4.61% -2.71% 5.16% 31.94% 17.09% -2.25% -17.26% 22.35% 26.87% -30.11% 18.41% -0.27% -1.35% -57.58% 231.19% -33.98% 6.72% -5.97% -10.31% 5.96% -22.65% -49.29% -0.03% 25.88% -15.10% 1.53%     
      net income margin %
    -2705.24% -16930.94% -5899.17% -9180.00% -4886.08% -1888.18% -8166.84% -1259.47% -2752.41% -386.92% -2241.55% -6264.13% -2433.12% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% -437.31%  
      net income per share
    -0.08 -0.13 -0.05 -0.06 -0.12 -0.14 -0.07 -0.11 -0.13 -0.1 -0.12 -0.12 -0.11 -0.08 -0.08 -0.08 -0.08 -0.08 -0.06 -0.09 -0.04 -0.03 -0.02 -0.02 -0.04 -0.03 -0.05 -0.08 -0.08 -0.13  -0.1 -0.09 -0.1 -0.07 -0.08 -0.08 -0.1 -0.08 -0.07 -0.07 -0.09 -0.07 -0.06 -0.09 -0.08 -0.08 -0.08 -0.23 -0.07 -0.13 -0.13 -0.14 -0.14 -0.15 -0.26 -0.58 -2.32 -0.07 -0.09 -0.09 -0.47 -0.86  
      weighted-average shares outstanding - basic and diluted
    308,650 273,136 295,461 254,658 235,933 209,510 213,004 208,665 196,748 182,802 188,306 177,302 174,703 165,958 165,687 165,238 164,563 160,662 163,985 158,818 155,454 139,829 143,685 140,107 127,214 111,297  106,872 101,971 86,983  81,321 78,610 72,786 74,922 69,373 68,113 51,958 52,111 51,567 47,566 46,540 47,216 46,663 44,963  43,858 43,015 34,842  28,448 26,493 25,240  24,974 19,167 17,027  109,238 106,176 102,697 21,508 11,917  
      gross loss
     -309,500 -716,000                                                              
      impairment loss on intangible assets
         1,154,000  3,027,000                                                         
      bargain purchase gain, net of tax
             -37,000   1,706,000                                                    
      gross margin
            -321,000                                     178,000 600,000 443,000 1,220,000 1,164,000 880,000 1,007,000 1,000,000 1,238,000 1,475,000 1,328,000 -2,600,000 -2,922,000 -881,000 -2,225,000 -1,420,000 263,000 775,000  
      provision for income taxes
                -181,000                                                    
      product revenue
                          100,000  1,247,000 4,147,000 999,000  199,000     2,000 2,298,000   2,547,000 3,617,000 3,530,000 3,155,000 1,451,000 2,078,000 2,182,000 741,000 348,000 16,000 19,000 9,000 29,000 176,000 917,000 1,219,000 2,488,000 2,015,000 750,000 1,529,000 1,023,000 1,525,000 904,000 886,000 572,000   
      license and royalty revenue
                   314,000 350,000 557,000 718,000 746,000 479,000 395,000 539,000 572,000 212,000 82,000 17,000    10,000,000                                  
      contract revenue
                           15,000 10,000 376,000 174,000 1,240,000 1,652,000 1,833,000 1,572,000 2,014,000 2,177,000 2,230,000 3,429,000 1,107,000 257,000 37,000 52,000 16,000 4,000 7,000 11,000 1,537,000 16,000 339,000 722,000 324,000 17,000 119,000 128,000 73,000 282,000 322,000 515,000 545,000 201,000 481,000 314,000 251,000 233,000 2,157,000   
      total revenue
                   314,000 350,000 557,000 718,000 746,000 479,000 395,000 639,000 587,000 1,469,000 4,605,000 1,190,000 1,240,000 1,851,000 1,833,000 11,572,000 2,014,000 2,188,000 2,560,000 6,086,000 1,453,000 792,000 2,905,000 4,000,000 4,155,000 3,701,000    901,000 687,000 968,000 611,000 1,219,000 1,217,000 964,000 1,870,000 1,801,000 2,727,000 2,613,000 1,295,000 1,730,000 1,504,000 1,839,000 1,155,000 1,119,000 2,729,000   
      cost of product revenue
                 33,000 45,000 18,000 4,000 48,000 -10,000 -31,000     1,395,000 3,340,000 2,039,000 1,025,000 288,000 3,470,000 1,434,000 326,000 238,000 787,000 3,224,000 135,000 213,000 2,378,000 2,767,000 2,587,000 2,588,000 1,463,000 1,810,000 2,074,000 1,037,000 200,000 5,000 33,000 -10,000 9,000 8,000 837,000 664,000 1,304,000 887,000 -281,000 4,175,000 3,932,000 2,483,000 2,985,000 2,240,000 886,000   
      cost of contract revenue
                            4,000 86,000 33,000 798,000 955,000 969,000 1,211,000 1,355,000 1,635,000 1,763,000 2,619,000 810,000 325,000 22,000 26,000 5,000 1,000 4,000 3,000 782,000 7,000 309,000 363,000 135,000 9,000 44,000 76,000 26,000 137,000 185,000 251,000 248,000 155,000 494,000 237,000 395,000 299,000 1,580,000   
      total cost of revenue
                 33,000 45,000 18,000 4,000 48,000 -10,000 -31,000     1,399,000 3,426,000 2,072,000 1,823,000 1,243,000 4,439,000 2,645,000 1,681,000 1,873,000 2,550,000 5,843,000 945,000 538,000 2,400,000 2,793,000 2,592,000 2,589,000    1,044,000 509,000 368,000 168,000  53,000 84,000 863,000 801,000 1,489,000 1,138,000 -33,000 4,330,000 4,426,000 2,720,000 3,380,000 2,539,000 2,466,000   
      gain on debt extinguishment
                      692,000                                              
      other expenses
                    -44,000 -4,000 -5,000 -8,000  -3,250           -12,000                                
      weighted-average shares outstanding - basic
                              114,874    93,073                                  
      weighted-average shares outstanding - diluted
                              114,874    93,204                                  
      royalty revenue
                                    11,000 328,000 359,000 346,000 535,000 321,000 331,000 609,000 542,000 388,000 309,000 324,000 144,000         20,750 83,000          
      development revenue
                                                  230,000 268,000 1,193,000 1,069,000 660,000 880,000 300,000            
      total revenues
                                             1,835,500 2,398,000 4,043,000                     
      total cost of revenues
                                             1,428,250 1,813,000 2,856,000                     
      gain on sale of previously reserved inventory
                                                 -8,000  -228,000 -227,000                
      loss on warrant exchange
                                                    -4,967,000                
      change in warrant liability
                                                     1,404,000 397,000              
      gain on warrant exchange
                                                                    
      interest income
                                                            10,000 11,000 9,000 12,000 15,000 43,000 706,000  
      gain on derivative instruments
                                                                    
      other expense
                                                                    
      marketing, general and administrative expense
                                                                 4,722,000 3,701,000  
      non-cash compensation expense
                                                                 212,000 463,000  
      realized gain on sale of investment securities
                                                                    
      loss before minority interests and equity in losses of lumera
                                                                    
      minority interests in loss of consolidated subsidiary
                                                                 54,000 554,000  
      equity in losses of lumera
                                                                    
      less: stated dividend on mandatorily redeemable convertible preferred stock
                                                                    
      non-cash accretion on preferred stock
                                                                    
      net loss available for common shareholders
                                                                 -10,094,000   
      loss before minority interests
                                                                  -10,774,000  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-03-31 2012-09-30 2012-06-30 2012-03-31 2011-09-30 2011-06-30 2011-03-31 2004-09-30 2001-03-31 2000-12-31 
                                                                  
        assets
                                                                  
        current assets
                                                                  
        cash and cash equivalents
      46,120,000 32,363,000 72,832,000 74,094,000 51,918,000 54,486,000 16,523,000 26,748,000 44,298,000 45,167,000 49,366,000 62,308,000 23,187,000 20,536,000 21,977,000 36,964,000 55,611,000 82,647,000 125,135,000 135,288,000 75,338,000 16,862,000 5,027,000 7,805,000 2,325,000 5,837,000 6,642,000 4,614,000 6,979,000 13,766,000 13,210,000 20,993,000 7,228,000 25,303,000 17,744,000 7,655,000 15,139,000 5,803,000 7,191,000 11,209,000 7,888,000 11,160,000 15,085,000 16,685,000 8,349,000 10,896,000 12,464,000 15,338,000 5,375,000 8,321,000 3,310,000 10,743,000 14,764,000 6,808,000 9,369,000 9,339,000 14,469,000 8,752,000 22,290,000 7,307,400 
        investment securities, available-for-sale
       42,471,000 26,676,000 17,313,000 17,126,000 20,216,000 26,679,000 29,934,000 28,770,000 28,611,000 28,677,000 31,565,000 44,544,000 62,173,000 61,281,000 55,926,000 47,651,000 32,720,000                                    13,000 8,000 9,000 12,000  31,784,000 33,410,000 
        restricted cash, current
      485,000 497,000 328,000 76,000 70,000 261,000 270,000 73,000 71,000 3,263,000 3,263,000 3,263,000 3,263,000                                                
        accounts receivable
      732,000 47,000 40,000 104,000 252,000 926,000 232,000 1,970,000 1,121,000 949,000 740,000 821,000 506,000            552,000 1,079,000 505,000 2,524,000 274,000 476,000 5,044,000 2,672,000 2,502,000 240,000 805,000 160,000 245,000 1,821,000 2,087,000 996,000 1,687,000 574,000 1,320,000 478,000 669,000 577,000 54,000 135,000 24,000 137,000 1,506,000 979,000 558,000 389,000 877,000 684,000 880,000 789,000 1,181,000 1,032,500 
        inventory
      4,028,000 745,000 8,131,000 6,128,000 2,534,000 2,294,000 4,486,000 4,203,000 3,738,000 3,874,000 3,616,000 2,933,000 3,116,000 1,861,000 1,762,000 1,833,000 1,815,000 1,780,000 1,182,000 151,000      192,000 241,000 54,000 1,062,000 1,109,000 3,347,000 4,505,000 4,519,000 4,253,000 2,677,000 2,052,000 1,233,000 1,252,000 1,118,000 906,000 862,000 269,000 348,000 432,000 116,000 79,000 31,000 49,000 49,000 28,000 217,000 622,000 866,000 1,119,000 4,443,000 5,042,000 5,423,000 2,781,000   
        other current assets
      2,858,000 4,989,000 6,969,000 5,468,000 7,100,000 4,287,000 4,857,000 3,646,000 4,302,000 4,890,000 5,765,000 2,332,000 2,182,000 2,306,000 2,832,000 1,027,000 1,865,000 2,283,000 2,780,000 885,000 565,000 698,000 748,000 301,000 413,000 729,000 574,000 951,000 1,091,000 1,311,000 893,000 1,221,000 1,547,000 3,192,000 4,233,000 810,000 731,000 461,000 626,000 590,000 638,000 543,000 542,000 541,000 491,000 458,000 547,000 256,000 336,000 420,000 699,000 606,000 501,000 925,000 1,120,000 978,000 477,000 800,000 2,575,000 975,600 
        total current assets
      54,223,000 81,112,000 114,976,000 103,183,000 79,000,000 82,470,000 53,047,000 66,574,000 82,300,000 86,754,000 91,427,000 103,275,000 76,990,000 91,008,000 87,852,000 95,750,000 106,942,000 119,430,000 129,097,000 136,324,000 75,903,000 17,560,000 5,775,000 8,106,000 3,290,000 7,837,000 7,962,000 8,143,000 10,605,000 17,649,000 23,574,000 29,391,000 16,054,000 32,988,000 25,459,000 10,986,000 17,348,000 9,337,000 11,022,000 13,701,000 11,075,000 12,546,000 17,295,000 18,136,000 9,625,000 12,010,000 13,096,000 15,778,000 5,784,000 8,918,000 5,744,000 12,962,000 16,701,000 9,317,000 16,074,000 16,490,000 21,690,000 14,128,000 58,905,000 45,966,900 
        property and equipment
      17,300,000 4,280,000 6,574,000 6,739,000 6,816,000 7,061,000 7,668,000 8,131,000 8,549,000 9,032,000 9,461,000 9,949,000 10,284,000 6,830,000 4,545,000 3,419,000 3,248,000 3,026,000 2,780,000 2,742,000 2,245,000 1,883,000 1,515,000 1,623,000 1,733,000 1,849,000 2,111,000 2,263,000 2,675,000 2,993,000 2,954,000 3,122,000 2,950,000 3,200,000 3,299,000 2,569,000 1,537,000 1,367,000 1,324,000 1,537,000 1,669,000 1,662,000 1,519,000 1,025,000 894,000 842,000 893,000 924,000 1,065,000 1,182,000 1,003,000 1,465,000 1,650,000 1,984,000 2,736,000 3,380,000 3,843,000 2,776,000 7,523,000 7,515,900 
        operating lease right-of-use assets
      17,929,000 14,075,000 15,365,000 16,123,000 16,306,000 16,746,000 12,090,000 12,348,000                                                     
        restricted cash, net of current portion
      1,189,000 1,204,000 1,374,000 1,621,000 1,537,000 1,500,000 1,572,000 1,961,000 1,968,000 961,000                                                   
        intangible assets
      13,662,000 32,000 10,281,000 10,510,000 10,739,000 10,972,000 12,563,000 13,081,000 16,662,000 17,235,000 17,766,000 18,321,000 19,000,000 75,000 85,000 95,000 105,000 115,000 127,000 139,000 152,000 164,000 178,000 192,000 207,000 221,000 306,000 428,000 457,000 486,000 515,000 544,000 573,000 631,000 660,000 689,000 718,000 750,000 781,000 813,000 845,000 877,000 909,000 941,000 973,000 1,046,000 1,079,000 1,112,000 1,145,000 1,462,000 1,540,000 1,910,000 1,956,000 2,002,000 2,094,000 2,140,000 2,186,000    
        goodwill
      3,677,000                                                            
        other assets
      2,224,000 2,416,000 2,252,000 2,441,000 2,345,000 2,412,000 1,322,000 1,321,000 1,491,000 1,895,000 2,110,000 1,335,000 1,281,000 1,086,000 1,005,000 1,028,000 1,014,000 985,000 974,000 24,000 25,000 18,000 18,000 18,000 18,000 186,000 186,000 1,494,000 1,470,000 1,470,000 2,492,000 2,498,000 2,506,000 50,000 58,000 144,000 68,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 18,000 22,000 22,000 34,000 30,000 30,000 30,000 232,000 2,099,000 113,900 
        total assets
      110,204,000 103,119,000 150,822,000 140,617,000 116,743,000 121,161,000 88,262,000 103,416,000 124,182,000 129,635,000 135,948,000 148,655,000 123,262,000 114,996,000 109,391,000 107,192,000 117,769,000 130,225,000 134,065,000 140,417,000 79,611,000 21,006,000 8,961,000 11,506,000 6,904,000 11,836,000 12,394,000 14,240,000 17,201,000 23,033,000 29,970,000 35,990,000 22,518,000 37,304,000 29,911,000 14,823,000 20,106,000 11,907,000 13,580,000 16,504,000 14,042,000 15,538,000 20,176,000 20,555,000 11,945,000 14,351,000 15,521,000 18,267,000 8,447,000 12,015,000 8,740,000 16,795,000 20,765,000 13,773,000 21,953,000 23,059,000 28,768,000 29,536,000 71,574,000 56,171,200 
        liabilities and shareholders’ equity
                                                                  
        current liabilities
                                                                  
        accounts payable
      4,537,000 1,628,000 1,339,000 1,564,000 1,268,000 1,132,000 1,487,000 1,448,000 2,161,000 2,271,000 2,294,000 1,890,000 3,629,000 2,061,000 1,519,000 1,415,000 1,919,000 3,584,000 1,394,000 1,540,000 698,000 630,000 1,513,000 1,498,000 2,113,000 1,871,000 1,091,000 1,705,000 2,003,000 2,411,000 1,631,000 2,275,000 1,989,000 3,858,000 1,852,000 2,237,000 2,195,000 2,149,000 2,496,000 2,354,000 2,183,000 1,627,000 1,971,000 2,152,000 1,626,000 1,660,000 1,715,000 1,369,000 1,610,000 1,809,000 2,314,000 3,877,000 4,348,000 6,406,000 6,301,000 6,785,000 6,808,000 2,621,000 1,346,000 1,974,500 
        accrued liabilities
      7,542,000 5,426,000 3,754,000 2,267,000 2,194,000 2,542,000 5,893,000 8,894,000 9,971,000 8,640,000 7,204,000 6,595,000 4,223,000 2,058,000 1,588,000 1,416,000 1,288,000 1,170,000 885,000 641,000 710,000 495,000 295,000 501,000 837,000 2,045,000 4,064,000 4,816,000 5,092,000 5,602,000 5,719,000 6,155,000 6,607,000 3,995,000 4,706,000 4,219,000 3,882,000 3,242,000 3,153,000 3,882,000 3,399,000 2,776,000 3,269,000 2,948,000 2,729,000 2,361,000 2,118,000 2,700,000 2,455,000 3,014,000 3,501,000 4,087,000 4,438,000 5,031,000 4,432,000 4,026,000 4,305,000 3,977,000 3,402,000 2,359,000 
        deferred revenue
      411,000                        15,000 21,000 28,000     5,000,000  999,000 999,000 999,000 999,000 2,184,000 1,904,000 1,203,000 2,122,000 1,002,000 1,284,000 1,224,000       363,000          
        derivative liability
      2,035,000  1,856,000 2,915,000 4,867,000 14,581,000                                                       
        notes payable
      32,141,000                                                            
        operating lease liabilities, current
      4,985,000 3,481,000 3,154,000 3,462,000 2,979,000 2,682,000 2,149,000 2,113,000                                                     
        finance lease liabilities, current
      13,000 14,000 14,000 13,000 9,000                                                        
        other current liabilities
      99,000 388,000 672,000  116,000 458,000 902,000 24,000 270,000 669,000 1,058,000  211,000 839,000 1,459,000  474,000 1,181,000 1,884,000      42,000 83,000 8,000 10,042,000 10,095,000 10,154,000 10,027,000 10,063,000 10,103,000 10,034,000 10,070,000                          
        total current liabilities
      51,763,000 30,149,000 39,899,000 42,829,000 41,854,000 45,951,000 10,611,000 12,651,000 17,751,000 20,503,000 24,066,000 22,698,000 22,155,000 11,426,000 9,961,000 8,055,000 9,404,000 12,462,000 11,384,000 10,399,000 10,101,000 10,028,000 11,615,000 12,078,000 12,962,000 14,456,000 15,866,000 17,333,000 17,859,000 18,188,000 17,391,000 23,939,000 18,703,000 20,339,000 21,294,000 7,582,000 7,244,000 7,575,000 7,553,000 7,439,000 7,704,000 5,410,000 6,529,000 6,733,000 4,585,000 4,124,000 3,953,000 4,421,000 9,662,000 11,777,000 6,963,000 8,187,000 9,114,000 12,175,000 10,914,000 10,982,000 11,284,000 6,808,000 5,413,000 5,415,500 
        warrant liability
      1,271,000 1,875,000 4,059,000 3,733,000 4,536,000                                            4,902,000 6,716,000           
        operating lease liabilities, net of current portion
      16,259,000 14,034,000 14,434,000 15,186,000 15,436,000 15,954,000 11,662,000 11,936,000                                                     
        finance lease liabilities, net of current portion
      21,000 27,000 31,000 30,000 25,000                                                        
        other long-term liabilities
      1,347,000 1,486,000 1,680,000 1,735,000 1,688,000 1,733,000 134,000 120,000 270,000 614,000 597,000 81,000 17,000                   21,000 163,000 27,000 36,000 45,000 53,000                    330,000    
        total liabilities
      70,661,000 47,571,000 60,103,000 63,513,000 63,539,000 72,392,000 22,407,000 24,707,000 30,379,000 33,831,000 37,690,000 36,150,000 36,724,000 25,255,000 23,766,000 13,092,000 14,301,000 17,471,000 11,718,000 11,520,000 11,650,000 11,997,000 13,154,000 14,028,000 14,178,000 15,813,000 17,363,000 18,970,000 19,633,000 18,916,000 17,922,000 24,376,000 19,232,000 24,827,000 26,086,000 12,673,000 12,632,000 13,203,000 13,472,000 13,646,000 14,195,000 12,192,000 13,599,000 14,088,000 5,073,000 4,647,000 4,510,000 4,954,000 10,143,000 12,205,000 6,968,000 8,221,000 9,226,000 12,396,000 11,342,000 11,687,000 12,456,000 6,905,000 6,053,000 6,129,500 
        commitments and contingencies
                                                                  
        shareholders’ equity
                                                                  
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding
                                                                  
        common stock
      322,000 306,000 302,000 278,000 245,000 225,000 213,000 212,000 206,000 195,000 190,000 188,000 176,000 171,000 166,000 165,000 165,000 164,000 164,000 164,000                                      22,000   
        additional paid-in capital
      1,021,218,000 1,011,835,000 1,009,272,000 981,597,000 943,900,000 910,825,000 896,424,000 894,005,000 885,119,000 860,765,000 843,975,000 835,410,000 787,856,000 772,221,000 754,702,000 750,311,000 746,028,000 742,042,000 738,991,000 736,159,000 660,267,000 601,224,000 578,326,000 577,172,000 570,128,000 568,496,000 564,227,000 558,334,000 551,650,000 550,133,000 546,123,000 545,978,000 529,205,000 528,623,000 514,737,000 507,572,000 507,249,000 493,123,000 490,459,000 489,734,000 483,171,000 482,372,000 482,090,000 479,212,000 475,656,000   471,997,000   442,932,000   426,031,000    197,096,000   
        accumulated other comprehensive income
      559,000 669,000 651,000 518,000 119,000  344,000 101,000 157,000                                                  787,000 454,200 
        accumulated deficit
      -982,556,000 -957,262,000 -919,506,000 -905,289,000 -891,060,000 -862,281,000 -831,126,000 -815,609,000 -791,679,000 -765,366,000 -745,629,000 -722,160,000 -701,551,000 -682,524,000 -669,049,000 -656,198,000 -642,601,000 -629,433,000 -616,808,000 -607,426,000 -592,464,000 -586,233,000 -582,663,000 -579,837,000 -577,533,000 -572,599,000 -569,315,000 -563,174,000 -554,184,000 -546,116,000 -534,168,000 -534,457,000 -525,998,000 -516,225,000 -510,984,000 -505,490,000 -499,843,000 -494,473,000 -490,403,000 -486,927,000 -483,371,000 -479,073,000 -475,560,000 -472,791,000 -468,829,000 -465,483,000 -462,128,000 -458,727,000 -450,709,000 -448,288,000 -441,185,000 -433,457,000 -429,612,000 -424,641,000 -405,032,000 -397,242,000 -388,067,000  -76,357,000 -66,137,200 
        total shareholders’ equity
      39,543,000 55,548,000 90,719,000 77,104,000 53,204,000 48,769,000 65,855,000 78,709,000 93,803,000 95,804,000 98,258,000 112,505,000 86,538,000 89,741,000                                            15,144,000   
        total liabilities and shareholders’ equity
      110,204,000 103,119,000 150,822,000 140,617,000 116,743,000 121,161,000 88,262,000 103,416,000 124,182,000 129,635,000 135,948,000 148,655,000 123,262,000 114,996,000                                               
        contract liabilities
        147,000 337,000 314,000 308,000 180,000 172,000 213,000 300,000 4,958,000 5,729,000 5,676,000 4,601,000 4,601,000 4,601,000 4,915,000 5,265,000 5,822,000 6,540,000 7,286,000 7,765,000 8,160,000 8,699,000 9,271,000 9,755,000 10,000,000                                  
        notes payable, current
       19,212,000 28,963,000 32,271,000 30,107,000 24,248,000                                                       
        notes payable, net of current portion
           8,754,000                                                       
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of december 31, 2025 and 2024
                                                                  
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
                                                                  
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
                                                                  
        accrued liability for ibeo business combination
              2,969,000 6,300,000 6,118,000 6,191,000 6,191,000                                                
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of december 31, 2024 and 2023
                                                                  
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of september 30, 2024 and december 31, 2023
                                                                  
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of june 30, 2024 and december 31, 2023
                                                                  
        operating lease right-of-use asset
              13,212,000 13,758,000 14,223,000 14,422,000 14,746,000 14,579,000 14,486,000 5,482,000 5,368,000 5,577,000 652,000 753,000 851,000 946,000 1,040,000 1,132,000 1,221,000 1,308,000 1,394,000 1,477,000 1,559,000                                
        current portion of operating lease liability
              2,167,000 2,323,000 2,432,000 2,285,000 2,210,000 1,846,000 769,000 590,000 686,000 849,000 691,000 686,000 680,000 676,000 671,000 666,000 661,000 656,000 651,000 646,000 642,000                                
        operating lease liability, net of current portion
              12,358,000 12,714,000 13,027,000 13,371,000 13,729,000 13,829,000 13,803,000 5,029,000 4,882,000 4,983,000 307,000 467,000 624,000 774,000 922,000 1,069,000 1,211,000 1,348,000 1,482,000 1,615,000 1,746,000                                
        advance to ibeo
                   4,132,000                                               
        current portion of finance lease obligations
                2,000 8,000 15,000 21,000 25,000 24,000 24,000 21,000 23,000 24,000 28,000 31,000 15,000 20,000 23,000  24,000 23,000 22,000                                
        preferred stock, par value 0.001; 25,000 shares authorized; zero and zero shares issued and outstanding, respectively
                                                                  
        accumulated other comprehensive gain
               210,000 45,000                                                  
        restricted cash
                961,000 961,000 961,000 1,418,000 1,418,000 1,418,000 1,092,000 1,092,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000 435,000  435,000 436,000         
        preferred stock, par value 0.001; 25,000 shares authorized; no and no shares issued and outstanding
                                                                  
        subscriptions receivable
                -323,000 -925,000          -6,135,000                                       
        deferred tax current
                 53,000                                                 
        non-current deferred tax assets
                 392,000                                                 
        accumulated other comprehensive loss
                 -8,000 57,000 -127,000 -194,000 -178,000 -124,000 -19,000                                    -30,000 -35,000 -34,000 -31,000    
        contract assets
                  192,000                                                
        deferred tax liabilities
                  823,000                                                
        current portion of long-term debt
                     9,000 98,000 392,000 685,000 968,000 699,000 431,000 961,000 694,000                           42,000 91,000 97,000 95,000 91,000 89,000 87,000 75,000 53,000 51,900 
        finance lease obligations, net of current portion
                    2,000 8,000 15,000 26,000 27,000 33,000 39,000 44,000  1,000 5,000 9,000 15,000 22,000 28,000                                
        liabilities and shareholders' equity
                                                                  
        shareholders' equity
                                                                  
        total shareholders' equity
                    85,625,000 94,100,000 103,468,000 112,754,000 122,347,000 128,897,000 67,961,000 9,009,000 -4,193,000 -2,522,000 -7,274,000 -3,977,000 -4,969,000 -4,730,000 -2,432,000 4,117,000 12,048,000 11,614,000 3,286,000 12,477,000 3,825,000 2,150,000 7,474,000  108,000 2,858,000 -153,000 3,346,000 6,577,000 6,467,000 6,872,000 9,704,000 11,011,000 13,313,000  -190,000 1,772,000 8,574,000 11,539,000 1,377,000 10,611,000 11,372,000 16,312,000  44,756,000 50,041,700 
        total liabilities and shareholders' equity
                    109,391,000 107,192,000 117,769,000 130,225,000 134,065,000 140,417,000 79,611,000 21,006,000 8,961,000 11,506,000 6,904,000 11,836,000 12,394,000 14,240,000 17,201,000 23,033,000 29,970,000 35,990,000 22,518,000 37,304,000 29,911,000 14,823,000 20,106,000  13,580,000 16,504,000 14,042,000 15,538,000 20,176,000 20,555,000 11,945,000 14,351,000 15,521,000 18,267,000  12,015,000 8,740,000 16,795,000 20,765,000 13,773,000 21,953,000 23,059,000 28,768,000    
        long-term debt
                         621,000 886,000 1,151,000 617,000 880,000                             17,000 42,000 91,000 114,000 137,000 42,000 276,000 289,600 
        preferred stock, par value 0.001; 25,000 shares authorized; zero and
                                                                  
        zero shares issued and outstanding
                                                                  
        157,952 and 152,926 shares issued and outstanding at march 31,
                                                                  
        2021 and december 31, 2020, respectively
                          158,000                                        
        zero shares issued and outstanding, respectively
                                                                  
        152,926 and 125,803 shares issued and outstanding at december 31,
                                                                  
        2020 and 2019, respectively
                           153,000                                       
        143,906 and 125,803 shares issued and outstanding at september 30,
                                                                  
        2020 and december 31, 2019, respectively
                            144,000 143,000 131,000                                    
        143,433 and 125,803 shares issued and outstanding at june 30,
                                                                  
        costs and estimated earnings in excess of billings on uncompleted contracts
                                  1,199,000 987,000 1,080,000  258,000   309,000              12,000 12,000 12,000 12,000 63,000 257,000 132,000 123,000 960,000 1,075,000 2,116,400 
        130,878 and 125,803 shares issued and outstanding at march 31,
                                                                  
        current portion of finance lease obilgations
                               25,000                                   
        deferred rent, net of current portion
                                   695,000 504,000 416,000 366,000 59,000 102,000 143,000 185,000 226,000 265,000 304,000 342,000 381,000 417,000 453,000 488,000 523,000 557,000 533,000 481,000 428,000   48,000 119,000 253,000 497,000 600,000 43,000 246,000 242,100 
        125,803 and 100,105 shares issued and outstanding at december 31,
                                                                  
        2019 and 2018, respectively
                               126,000                                   
        119,417 and 100,105 shares issued and outstanding at september 30,
                                                                  
        2019 and december 31, 2018, respectively
                                119,000 110,000 102,000                                
        billings on uncompleted contracts in excess of related costs
                                 101,000 5,000  1,000 446,000 4,000 1,453,000 3,667,000 127,000 168,000     5,000 5,000 409,000 230,000                
        110,223 and 100,105 shares issued and outstanding at june 30,
                                                                  
        102,105 and 100,105 shares issued and outstanding at march 31,
                                                                  
        current portion of capital lease obilgations
                                   21,000                               
        capital lease obligations, net of current portion
                                   33,000 27,000                    5,000 34,000 47,000 60,000 84,000 94,000 105,000 12,000 118,000 182,300 
        100,105 and 78,597 shares issued and outstanding at december 31,
                                                                  
        2018 and 2017, respectively
                                   100,000                               
        current portion of capital lease obligations
                                    13,000                 5,000 15,000 29,000 51,000 46,000 44,000 41,000 40,000 35,000 37,000 48,000 289,000 316,500 
        93,073 and 78,597 shares issued and outstanding at september 30,
                                                                  
        2018 and december 31, 2017, respectively
                                    93,000 93,000 79,000                            
        93,073 and 78,597 shares issued and outstanding at june 30,
                                                                  
        78,613 and 78,597 shares issued and outstanding at march 31,
                                                                  
        deferred revenue, net of current portion
                                       4,402,000 4,654,000 4,903,000 5,150,000 5,402,000 5,654,000 5,903,000 6,149,000 6,401,000 6,653,000 6,902,000                 
        68,093 shares issued and outstanding
                                       79,000 72,000 68,000                         
        68,093 and 47,423 shares issued and outstanding at december 31,
                                                                  
        2016 and 2015, respectively
                                          68,000                        
        liabilities and shareholders' deficit
                                                                  
        shareholders' deficit
                                                                  
        47,423 shares issued and outstanding
                                           54,000 52,000 51,000                     
        total shareholders' deficit
                                           -1,296,000                       
        total liabilities and shareholders' deficit
                                           11,907,000                       
        47,423 and 44,758 shares issued and outstanding at december 31,
                                                                  
        2015 and 2014, respectively
                                              47,000                    
        44,758 shares issued and outstanding
                                               47,000 47,000 46,000                 
        preferred stock, par value 0.001; 25,000 shares authorized; 0 and
                                                                  
        0 shares issued and outstanding
                                                                  
        preferred stock, par value .001; 25,000 shares authorized; 0 and
                                                                  
        and 32,069 shares issued and outstanding at december 31, 2014
                                                                  
        and 2013, respectively
                                                  45,000                
        billings in excess of costs and estimated earnings on uncompleted contracts
                                                   103,000 120,000 347,000 680,000 209,000 692,000 86,000 187,000 602,000 50,000 47,000 47,000 56,000 73,000 418,600 
        32,069 shares issued and outstanding
                                                   44,000 44,000 43,000             
        additonal paid-in capital
                                                   475,143,000 473,095,000  448,981,000 448,066,000  442,006,000 441,126,000  415,560,000 408,540,000 404,305,000    
        shareholders' (deficit) equity
                                                                  
        and 25,237 shares issued and outstanding at december 31, 2013
                                                                  
        and 2012, respectively
                                                      32,000            
        total shareholders' (deficit) equity
                                                      -1,696,000            
        total liabilities and shareholders' (deficit) equity
                                                      8,447,000            
        restricted investments
                                                       435,000   436,000 436,000 1,019,000 1,019,000 1,019,000 1,238,000 903,000 951,000 
        25,237 shares issued and outstanding
                                                       32,000 25,000          
        17,019 shares issued and outstanding
                                                         25,000 25,000 17,000       
        current restricted investments
                                                             306,000 306,000   1,125,000 
        102,471 shares issued and outstanding
                                                            118,000 108,000 105,000    
        receivable from lumera
                                                               46,000   
        investment in lumera
                                                               11,162,000   
        liabilities, mandatorily redeemable convertible preferred stock and shareholders’ equity
                                                                  
        allowance for estimated contract losses
                                                               31,000 250,000 295,000 
        research liability, net of current portion
                                                                  
        minority interest
                                                                20,765,000  
        mandatorily redeemable convertible preferred stock, par value .001; 25,000 shares authorized; 10 and 0 shares issued and outstanding
                                                               7,487,000   
        deferred compensation
                                                                -3,723,000 -4,378,200 
        subscriptions receivable from related parties
                                                                -347,000 -403,200 
        receivables from related parties
                                                                1,520,000 999,900 
        total liabilities, mandatorily redeemable convertible preferred stock and shareholders’ equity
                                                               29,536,000   
        long-term investment, at cost
                                                                624,000 623,600 
        common shares, ...
                                                                124,396,000  
        11,884 shares issued and outstanding
                                                                  
        total liabilities, mandatorily redeemable convertible preferred stock and shareholders' equity
                                                                71,574,000  
        liabilities, mandatorily redeemable convertible
                                                                  
        preferred stock and shareholders' equity
                                                                 56,171,200 
        mandatorily redeemable convertible preferred stock, no par
                                                                  
        value, 1,600 shares authorized; 0 and 1,600 issued and outstanding
                                                                  
        authorized; 11,883,540 and 10,140,733 shares issued
                                                                  
        and outstanding
                                                                 120,506,100 
        total liabilities, mandatorily redeemable convertible
                                                                  
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2012-03-31 2011-06-30 2011-03-31 2001-03-31 
                                                             
          cash flows from operating activities
                                                             
          net loss
        -25,294,000 -37,756,000 -14,217,000 -14,229,000 -28,779,000 -31,155,000 -15,517,000 -23,930,000 -26,313,000 -19,737,000 -23,469,000 -20,609,000 -19,027,000 -13,475,000 -12,851,000 -13,597,000 -13,168,000 -12,625,000 -9,382,000 -14,962,000 -6,231,000 -3,570,000 -2,826,000 -2,304,000 -4,934,000 -3,284,000 -6,141,000 -8,990,000 -8,068,000 -11,948,000 289,000 -8,459,000 -7,132,000 -5,241,000 -5,494,000 -5,647,000 -3,476,000 -3,556,000 -4,298,000 -3,513,000 -2,769,000 -3,962,000 -3,346,000 -3,355,000 -3,401,000 -8,018,000 -2,421,000 -3,667,000 2,713,000 -9,803,000 -9,175,000 -9,037,000 -10,220,000 
          adjustments to reconcile net loss to net cash from operations:
                                                             
          depreciation and amortization
        2,368,000 1,477,000 1,395,000 1,544,000 1,408,000 1,674,000 1,676,000 1,770,000 1,800,000 1,576,000 2,137,000 1,627,000 2,524,000 821,000 524,000 418,000 483,000 424,000 375,000 366,000 299,000 237,000 238,000 242,000 246,000 267,000 279,000 551,000 552,000                         
          unrealized gain on derivative liability
        -3,380,000  -1,059,000 -1,952,000 -842,000                                                 
          unrealized gain on warrant liability
        -604,000 -2,184,000 326,000 -803,000 -1,761,000                                                 
          loss on debt extinguishment
        3,083,000 4,654,000                                                 
          bargain purchase gain
        -147,000                                                     
          gain on disposal of fixed assets
        -108,000         -9,000 -10,000              -450,000                             
          impairment of operating lease right-of-use assets
        9,000     -1,000 13,000                                               
          inventory write-downs
        27,000     1,918,000 79,000 39,000 9,000 15,000 5,000 27,000 29,000 27,000 43,000       168,000 1,351,000   3,275,000 1,135,000 4,000 165,000   49,000 122,000 148,000 139,000 17,000   -791,000 1,094,000 483,000 461,000  
          non-cash interest expense
         7,325,000              -17,000 4,000 3,000 4,000 4,000                               
          amortization of debt discount and issuance costs on notes payable
        2,743,000 1,249,000 2,192,000 2,164,000 5,559,000                                                 
          share-based compensation expense
        983,000 -1,547,000 -1,603,000 1,930,000 1,921,000 2,013,000 2,426,000 3,353,000 3,743,000 4,635,000 4,691,000 3,866,000 2,949,000 3,526,000 4,081,000 4,120,000 3,734,000 2,939,000 2,810,000 7,897,000 1,638,000 458,000 450,000 200,000 189,000 692,000 258,000 268,000 351,000  182,000 219,000 320,000 324,000 393,000 310,000                  
          net accretion of premium on short-term investments
        -81,000 -248,000 -89,000 -77,000 -118,000 -175,000 -241,000 -247,000 -288,000 -289,000 -291,000 -299,000 -396,000 -269,000 21,000 109,000 160,000                                     
          change in:
                                                             
          accounts receivable
        -685,000 -7,000 64,000 148,000 674,000 -694,000 1,738,000 -849,000 -172,000 -209,000 81,000 -315,000 -506,000         552,000 527,000 -574,000 2,019,000 -2,250,000 202,000 4,568,000 -2,372,000 -170,000 -2,487,000 565,000 -645,000 85,000 -1,091,000 691,000 -1,113,000 746,000 -842,000 191,000 -92,000 -523,000 81,000 -111,000 113,000 951,000 -47,000 74,000 196,000 236,000 -148,000 
          inventory
        490,000 -2,478,000 -2,002,000 -3,568,000 -228,000 228,000 -313,000 -512,000 102,000 -273,000 -688,000 156,000 -87,000 -126,000 28,000 -35,000 -35,000 -646,000 -1,031,000   24,000 49,000 -1,538,000 156,000 47,000 -1,037,000 23,000 14,000 18,000 -1,741,000 -662,000 -819,000 -261,000 -166,000 -593,000 79,000 -64,000 -455,000 -37,000    -21,000 16,000 -1,891,000 2,041,000 -102,000 191,000  
          other current and non-current assets
        308,000 4,028,000 -1,960,000 2,503,000 -2,713,000 -521,000 -1,212,000 826,000 992,000 1,118,000 -3,183,000 -678,000 647,000 445,000 -1,875,000 824,000 389,000 486,000 -2,845,000 -319,000 126,000 50,000 -447,000 100,000 451,000 -110,000 1,685,000 116,000 220,000 761,000 195,000 409,000 -702,000 1,037,000 -3,200,000 -271,000 -36,000 48,000 -104,000 -13,000 16,000 -46,000            
          accounts payable
        2,800,000 289,000 -225,000 337,000 95,000 -355,000 66,000 -323,000 -527,000 46,000 650,000 -1,383,000 1,629,000 423,000 -286,000 -582,000 -1,292,000 1,947,000 -230,000 739,000 64,000 -1,047,000 15,000 -597,000 242,000 714,000 -570,000 -219,000 -193,000 337,000 -201,000 -205,000 -1,010,000 2,046,000 43,000 -320,000 221,000 141,000 546,000 -301,000 -133,000 381,000 -135,000 91,000 293,000 -274,000 -73,000 -367,000 -254,000 -792,000 -35,000 -985,000 -628,000 
          accrued liabilities
        2,116,000 1,797,000 1,362,000 73,000 -348,000 -3,351,000 -3,001,000 -1,077,000 1,331,000 2,250,000 183,000 2,121,000 2,017,000 470,000 172,000 128,000 118,000 285,000 244,000 -69,000 215,000 200,000 -206,000 -336,000 -1,208,000 -2,019,000 -752,000 -276,000 -332,000 -186,000 -471,000 -472,000 755,000 -852,000 639,000 315,000 -650,000 383,000   301,000 207,000   -502,000 272,000 -491,000 -125,000 -665,000 -106,000 -313,000 142,000 1,043,000 
          contract liabilities and other current liabilities
        122,000 -431,000 482,000 -108,000 -342,000 -297,000 874,000 -285,000 -480,000 -5,047,000 287,000 -981,000 -711,000 93,000 1,459,000 -788,000 -1,057,000 -1,260,000 1,166,000 -746,000 -479,000 -395,000 -539,000 -614,000 -525,000 -170,000                            
          operating lease liabilities
        -1,086,000 -848,000 -1,091,000 -541,000 -556,000 -547,000 -645,000 -660,000 -639,000 -687,000 -717,000 -427,000 -669,000 -342,000 -319,000 -320,000 -299,000 -256,000 -171,000 -169,000 -166,000 -165,000 -166,000 -164,000 -161,000 -161,000 -160,000 -161,000 -160,000                         
          other long-term liabilities
        -107,000 -197,000 -63,000 -150,000 -47,000 1,640,000 -12,000 -146,000 -330,000 -4,000 -64,000 64,000 17,000                 -21,000 -142,000 -142,000 -9,000                 -330,000 -94,000  
          net cash from operating activities
        -16,443,000 -15,405,000 -16,488,000 -12,729,000 -14,098,000 -15,056,000 -14,091,000 -18,634,000 -20,759,000 -16,578,000 -20,388,000 -16,642,000 -13,482,000 -8,403,000 -9,012,000 -9,697,000 -10,907,000 -8,159,000 -9,968,000 -6,746,000 -4,531,000 -4,228,000 -3,477,000 -2,933,000 -5,437,000 -4,310,000 -3,375,000 -8,711,000 -7,647,000 -3,110,000 -7,209,000 -2,697,000 -9,556,000 -5,688,000 4,570,000 -6,729,000 -4,116,000 -2,982,000 -3,666,000 -3,622,000 -3,589,000 5,050,000 -3,043,000 -3,243,000 -3,735,000 -2,931,000 -2,708,000 -3,653,000 -105,000 -6,191,000 -7,391,000 -8,141,000 -9,008,000 
          capital expenditures
        -143,000 -244,000 -128,000 -208,000 -99,000 -103,000 9,000 -166,000 -114,000 46,000 -497,000 -869,000 -615,000 -2,342,000 -889,000 -244,000 -884,000 -459,000 -150,000 -1,319,000 -565,000 -308,000 -19,000 -75,000 -74,000 -158,000 -200,000 -313,000 -147,000 -469,000 -320,000 -182,000 -448,000 -1,245,000 -755,000 -111,000 -82,000 -129,000 -292,000 -650,000 -69,000 -34,000 -64,000 -32,000 -77,000 -187,000 307,000 -393,000 -131,000 -64,000 -514,000 
          free cash flows
        -16,586,000 -15,649,000 -16,616,000 -12,937,000 -14,197,000 -15,159,000 -14,082,000 -18,800,000 -20,873,000 -16,532,000 -20,885,000 -17,511,000 -14,097,000 -10,745,000 -9,901,000 -9,941,000 -11,791,000 -8,618,000 -10,118,000 -8,065,000 -5,096,000 -4,536,000 -3,477,000 -2,952,000 -5,512,000 -4,384,000 -3,533,000 -8,911,000 -7,960,000 -3,257,000 -7,678,000 -3,017,000 -9,738,000 -6,136,000 3,325,000 -7,484,000 -4,227,000 -3,064,000 -3,795,000 -3,914,000 -4,239,000 4,981,000 -3,077,000 -3,307,000 -3,767,000 -3,008,000 -2,708,000 -3,840,000 202,000 -6,584,000 -7,522,000 -8,205,000 -9,522,000 
          cash flows from investing activities
                                                             
          sales of investment securities
        42,528,000 3,446,000 4,286,000 8,880,000 13,522,000 7,100,000 5,656,000 14,755,000 7,900,000 15,000,000 13,000,000 26,700,000 22,000,000 25,876,000 20,200,000 13,000,000 1,500,000                                    2,000,000 
          purchases of investment securities
         -18,981,000 -13,552,000 -8,993,000 -10,333,000 -495,000 -2,082,000 -15,683,000 -7,805,000 -14,609,000 -9,799,000 -13,404,000 -3,898,000 -26,432,000 -25,592,000 -21,438,000 -16,696,000                                    -41,000 
          purchases of property and equipment
        -143,000 -244,000 -128,000 -208,000 -99,000 -103,000 9,000 -166,000 -114,000 46,000 -497,000 -869,000 -615,000 -2,342,000 -889,000 -244,000 -884,000 -459,000 -150,000 -1,319,000 -565,000 -308,000 -19,000 -75,000 -74,000 -158,000 -200,000 -313,000 -147,000 -469,000 -320,000 -182,000 -448,000 -1,245,000 -755,000 -111,000 -82,000 -129,000 -292,000 -650,000 -69,000 -34,000 -64,000 -32,000 -77,000  -187,000 307,000 -393,000 -131,000 -64,000 -514,000 
          cash paid for business combination
        -33,178,000                                                     
          net cash from investing activities
        9,207,000 -18,023,000 -9,394,000 -321,000 3,090,000 6,502,000 3,583,000    2,704,000 12,427,000 6,254,000 -7,030,000 -6,281,000 -8,682,000 -16,080,000 -33,284,000 -150,000 -1,319,000 -565,000 -308,000 -19,000 450,000 -74,000 -158,000 -200,000 -313,000 -147,000 -469,000 -320,000 -182,000 -448,000 -1,245,000 -755,000 -111,000 -82,000 -129,000 -292,000 -650,000 -69,000 -34,000 -58,000 -4,000 -77,000 -103,000 -154,000 -40,000 -43,000 -131,000 113,000 2,618,000 
          cash flows from financing activities
                                                             
          principal payments under finance leases
        -3,000 -3,000 -4,000 -4,000 -2,000     -2,000 -6,000 -7,000 -6,000 -6,000 -5,000 -7,000 -8,000 -3,000 -7,000   -10,000 -6,000   -5,000                            
          principal proceeds from notes payable, net of debt discount and issuance costs
        20,732,000                                                     
          net proceeds from issuance of common stock and warrants
        311,000 4,106,000 29,979,000 35,082,000 8,207,000                          -242,000   13,695,000   209,000 6,385,000 523,000 -11,000 2,639,000 3,355,000 530,000 1,733,000 870,000 12,981,000 -121,000 6,156,000   2,426,000 3,116,000  
          net cash from financing activities
        21,040,000 -6,889,000 24,475,000 35,078,000 8,205,000 46,735,000 -16,000 5,153,000 21,018,000 11,675,000 4,742,000 43,336,000 12,685,000 13,992,000 306,000 58,000 -49,000 -388,000 -35,000 68,015,000 63,572,000 16,371,000 699,000 8,432,000 1,475,000 3,579,000 5,561,000 6,546,000 1,173,000 3,813,000 -105,000   13,695,000   209,000 6,385,000 523,000 -11,000 2,639,000 3,355,000 530,000 1,733,000 865,000 12,971,000 -135,000 6,125,000 5,565,000 -33,000 2,392,000 3,084,000 21,373,000 
          effect of exchange rate changes on cash, cash equivalents, and restricted cash
        -74,000  150,000 238,000 81,000                                                 
          change in cash, cash equivalents, and restricted cash
        13,730,000 -40,470,000 -1,257,000 22,266,000 -2,722,000 37,882,000 -10,417,000 -17,555,000 -3,054,000 -4,199,000 -12,942,000 39,121,000 5,457,000 -1,441,000 -14,987,000 -18,321,000 -27,036,000 -41,831,000 -10,153,000 59,950,000 58,476,000 11,835,000 -2,778,000 5,480,000 -3,512,000 -805,000 2,028,000 -2,365,000 -6,787,000 556,000 -7,783,000 13,765,000 -9,738,000                     
          cash, cash equivalents, and restricted cash at beginning of period
        34,064,000 56,247,000 49,391,000 21,954,000 83,739,000 17,297,000 6,272,000 14,201,000 17,401,000                     
          cash, cash equivalents, and restricted cash at end of period
        47,794,000 -40,470,000 -1,257,000 22,266,000 53,525,000 37,882,000 -10,417,000 -17,555,000 46,337,000 -4,199,000 -12,942,000 39,121,000 27,411,000 -1,441,000 -14,987,000 -18,321,000 56,703,000 -41,831,000 -10,153,000 59,950,000 75,773,000 11,835,000 -2,778,000 5,480,000 2,760,000 -805,000 2,028,000 -2,365,000 7,414,000 556,000 -7,783,000 13,765,000 7,663,000                     
          supplemental schedule of non-cash investing and financing activities
                                                             
          common stock issued in conversions of notes payable
        8,105,000  21,980,000                                                 
          issuance of warrants
         6,297,000                                                 
          acquisition of right-of-use asset
        4,733,000 -2,000 72,000 174,000 -107,000        234,000                                         
          accrued financing fees
            41,000   -386,000 396,000 -133,000 -79,000                                           
          foreign currency translation adjustment
        -86,000  125,000 402,000 138,000    -19,000                                             
          unrealized loss on investment securities, available-for-sale
        -24,000                                                     
          bargain purchase gain, net of tax
                  -1,706,000                                         
          loss on disposal of fixed assets
                                                             
          unrealized loss on derivative liability
                                                             
          impairment of intangible assets
             1,154,000                   63,000                            
          impairment of property and equipment
                13,000   4,000 60,000 218,000       230,000                            
          advance to scantinel
                                                             
          cash paid for ibeo business combination
             -3,037,000 -3,263,000 -11,233,000                                         
          principal payments under notes payable
         -11,000,000                                                    
          proceeds from stock option exercises
             62,000 7,000   -1,000 311,000 163,000 253,000                                     
          effect of exchange rate changes on cash and cash equivalents and restricted cash
             -299,000 107,000                                               
          common stock issued in conversion of note payable
                                                             
          amounts issued to escrow for acquisition consideration
                  3,263,000                                         
          foreign currency translation adjustments
             -311,000 165,000    31,000 -83,000 107,000                                         
          unrealized gain on investment securities, available-for-sale
         12,000                                                    
          adjustments to reconcile net loss to net cash used in operations:
                                                             
          non-cash additions to property and equipment
                21,000   -536,000 703,000 119,000 390,000 78,000 177,000 252,000 134,000 79,000 85,000 97,000 -18,000 37,000 -11,000 33,000 -206,000 221,000 296,000 -237,000 285,000 101,000 -40,000 -428,000 713,000 -38,000 154,000 10,000 -32,000 -59,000 246,000            
          accrued liability for ibeo business combination
                2,969,000                                             
          unrealized gain in investment securities, available-for-sale
            -19,000    -34,000                                             
          advance to ibeo
                                                             
          net proceeds from issuance of common stock
             8,655,000 -16,000 5,153,000 20,956,000 11,677,000 4,741,000 43,175,000 12,691,000     -2,551,000 -28,000 68,025,000 57,445,000 16,381,000 705,000 6,868,000 1,481,000 3,584,000 5,567,000 6,551,000 1,177,000                        175,000 
          issuance of common stock for subscriptions receivable
                                                             
          contract assets
                    -192,000                                         
          net cash from (used in) investing activities
                -3,282,000                                             
          effect of exchange rate changes on cash and cash equivalents
                -31,000                                             
          settlement of preexisting advance to ibeo in exchange for net assets acquired
                    4,132,000                                         
          non-cash interest income
                                                             
          gain on debt extinguishment
                                                             
          principal payments under long-term debt
                     -98,000 -294,000                                 -23,000 -21,000 -20,000 -13,000 
          payments received on subscriptions receivable
                         6,135,000                                56,000 
          acquisition of right-to-use asset operating lease
                                                             
          currency gain in translation
                                                             
          acquisition of right-to-use asset
                                                             
          issuance of common stock for subscription receivable
                                                             
          amounts held back for acquisition consideration
                    2,928,000                                         
          gain on disposal of property and equipment
                                                 -1,000         
          deferred revenue
                               -7,000        -252,000 -249,000 -247,000 452,000 -1,165,000 868,000 -534,000 -189,000 8,126,000     -28,000      
          proceeds on sale of property and equipment
                             525,000                  6,000   33,000   7,000  
          proceeds from long-term debt
                                                            
          property and equipment acquired under finance leases
                                                             
          lease liabilities from obtaining right-of-use operating asset
                                                             
          the following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of december 31, 2022, 2021 and 2020:
                                                             
          gain on extinguishment of debt
                                                             
          costs and estimated earnings in excess of billings on uncompleted contracts
                                 1,199,000 -212,000 93,000 -1,080,000 258,000 422,000   -184,000              7,000 -9,000 14,000 1,041,000 
          issuance of common stock for commitment fee
                                 277,000                           
          increase in long-term debt
                                                             
          the following table provides a reconciliation of the cash, cash equivalents, and
                                                             
          restricted cash balances as of march 31, 2021 and december 31, 2020:
                                                             
          cash and cash equivalents
                            75,338,000 11,835,000 -2,778,000 5,480,000 2,325,000 -805,000 2,028,000 -2,365,000 6,979,000 556,000 -7,783,000 13,765,000 7,228,000                     
          restricted cash
                            435,000 435,000 435,000 435,000                     
          cash, cash equivalents, and restricted cash
                            75,773,000    2,760,000    7,414,000                         
          the following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of
                                                             
          december 31, 2020 and december 31, 2019:
                                                             
          cash, cash equivalents and restricted cash
                             11,835,000 -2,778,000   -805,000 2,028,000   556,000 -7,783,000 13,765,000 7,663,000                     
          september 30, 2020 and december 31, 2019:
                                                             
          billings on uncompleted contracts in excess of related costs
                                   96,000 5,000     -2,214,000 3,540,000 -41,000   -5,000 -404,000 179,000            
          june 30, 2020 and december 31, 2019:
                                                             
          march 31, 2020 and december 31, 2019:
                                                             
          other non-cash adjustments
                                     104,000 122,000 -13,000 -10,000 -16,000 -15,000 -16,000 61,000 1,000 -16,000 -15,000 -16,000 -15,000            
          increase in deferred rent
                                                            
          december 31, 2019 and december 31, 2018:
                                                             
          september 30, 2019 and december 31, 2018:
                                                             
          other current liabilities
                                   -53,000 -59,000 127,000 -36,000 -40,000 -39,000                     
          june 30, 2019 and december 31, 2018:
                                                             
          march 31, 2019 and december 31, 2018:
                                                             
          depreciation
                                     428,000 442,000 433,000 419,000 507,000 87,000 85,000 209,000 187,000 132,000 117,000 97,000 83,000 83,000 81,000 92,000 158,000 196,000 241,000 -127,000 613,000 573,000 518,000 507,000 
          amortization of intangible assets
                                     29,000 29,000 29,000 29,000 29,000 29,000 29,000 32,000 32,000 32,000 32,000 32,000 32,000 33,000 33,000 33,000 33,000 40,000 39,000 33,000 46,000 46,000 47,000  
          non-cash share-based compensation expense
                                             300,000 289,000 294,000 234,000 190,000  211,000 201,000 305,000        
          principal payments under capital leases and long-term debt
                                                  -5,000 -10,000 -14,000 -31,000      
          net proceeds from issuance of common stock and exercise of warrants
                                                             
          property and equipment acquired under capital leases
                                     24,000                        
          december 31, 2018 and december 31, 2017:
                                                             
          the following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of september 30, 2018 and december 31, 2017:
                                                             
          the following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of june 30, 2018 and december 31, 2017:
                                                             
          march 31, 2018 and december 31, 2017:
                                                             
          other currrent liabilities
                                         -36,000                    
          change in cash and cash equivalents
                                         7,559,000 10,089,000 -7,484,000 -4,018,000 3,321,000  -3,925,000 -1,600,000 8,336,000            
          cash and cash equivalents at beginning of period
                                         15,139,000 7,888,000 8,349,000 5,375,000 -6,225,000 13,075,000 19,413,000 7,307,000 
          cash and cash equivalents at end of period
                                         7,559,000 10,089,000 7,655,000 -4,018,000 11,209,000 -3,272,000 -3,925,000 -1,600,000 16,685,000 -2,547,000 -1,568,000 -2,874,000 15,338,000 -2,946,000 2,318,000 -805,000 6,808,000 -5,130,000 14,469,000 22,290,000 
          loss on warrant exchange
                                                             
          net increase in cash and cash equivalents
                                                  -2,547,000 -1,568,000 -2,874,000 9,963,000  2,318,000     14,983,000 
          issuance of common stock for exchange of warrants
                                                  9,869,000 329,000       
          adjustments to reconcile net loss to net cash from operating activities:
                                                             
          supplemental disclosure of cash flow information
                                                             
          cash paid for interest
                                              1,000 1,000 1,000 1,000   2,000 2,000 -1,000 9,000 12,000 13,000  
          non-cash share-based compensation
                                                             
          change in warrant liability
                                                      -1,404,000       
          realized loss on warrant exchange
                                                   4,967,000        
          non-cash deferred rent
                                                   -16,000 -16,000 -15,000 -15,000   -44,000 -69,000 -69,000 4,000 
          other current assets
                                                   76,000 -279,000 85,000 79,000 -110,000 1,039,000 -140,000 -53,000 87,000 -597,000 
          other assets
                                                        -12,000 -71,000 
          billings in excess of costs and estimated earnings on uncompleted contracts
                                                   -17,000 -227,000 -333,000 471,000 -654,000 319,000 446,000 -34,000 -346,000 
          decrease in restricted investment
                                                      -349,000 350,000 170,000  
          other non-cash additions to property and equipment
                                                      -24,000 45,000 300,000 86,000 -21,000 229,000  
          warrant liability
                                                             
          decrease in restricted cash
                                                             
          realized loss on sale of short-term investments
                                                             
          realized gain on warrant exchange
                                                             
          purchases of property and equipment and intangible assets
                                                             
          net decrease in cash and cash equivalents
                                                         -6,267,000 -5,130,000 -4,944,000  
          non-cash stock-based compensation expense
                                                       515,000 108,000 373,000 1,397,000 401,000  
          realized gain on exchange of warrants
                                                             
          principal payments under capital leases
                                                         -10,000 -13,000 -12,000 -92,000 
          gain on derivative instruments
                                                             
          purchases of restricted investment securities
                                                             
          issuance of common stock for prepayment of salaries
                                                             
          adjustments to reconcile net loss to net cash from operations
                                                             
          gain on disposal of fixed asset
                                                             
          non-cash expenses related to issuance of stock, warrants, options and amortization of deferred compensation
                                                            1,526,000 
          allowance for receivables from related parties
                                                             
          realized gain on sale of investment securities
                                                             
          minority interests in loss of consolidated subsidiary
                                                            -554,000 
          equity in losses of lumera
                                                             
          non-cash interest on notes payable
                                                             
          allowance for estimated contract losses
                                                            -45,000 
          change in
                                                             
          intercompany receivable
                                                             
          research liability, current and long-term
                                                             
          net cash used in operating activities
                                                             
          sales of restricted investment securities
                                                            1,173,000 
          collections of receivables from related parties
                                                             
          net cash provided by investing activities
                                                             
          proceeds from issuance of notes
                                                             
          payment of preferred dividend
                                                             
          net proceeds from issuance of preferred stock and warrants
                                                             
          net proceeds from sale of subsidiary’s equity to minority interests
                                                             
          net cash provided by financing activities
                                                             
          net increase (decrease) in cash and cash equivalents
                                                             
          change in cash due to lumera deconsolidation
                                                             
          other current asset received in exchange for fixed assets
                                                             
          receivables from related parties
                                                            -520,000 
          net proceeds from sale of subsidiary's equity to minority interests
                                                            21,247,000 
          adjustments to reconcile net loss to net cash used in operations
                                                             
          non-cash expenses related to issuance of stock, warrants
                                                             
          and options, and amortization of deferred compensation
                                                             
          purchase of long-term investment
                                                             
          net proceeds from issuance of preferred stock
                                                             
          cash and cash equivalents at beginning of year
                                                             
          cash and cash equivalents at end of year
                                                             
          beneficial conversion feature of series b preferred stock
                                                             
          non-cash dividend on series b preferred stock
                                                             
          conversion of preferred stock to common stock
                                                             
          payment for exclusive license agreement by issuance of common stock
                                                             
          exercise of stock options for subscriptions receivable
                                                             
          deferred compensation - warrants, options and stock grants